Your browser doesn't support javascript.
loading
Precision Population Cancer Medicine in Cancer of the Uterine Cervix: A Potential Roadmap to Eradicate Cervical Cancer.
Nittala, Mary R; Yang, Johnny; Velazquez, Alexander E; Salvemini, John D; Vance, Gregory R; Grady, Camille C; Hathaway, Bradley; Roux, Jeffrey A; Vijayakumar, Srinivasan.
Afiliação
  • Nittala MR; Radiation Oncology, University of Mississippi Medical Center, Jackson, USA.
  • Yang J; Radiation Oncology, University of Mississippi Medical Center, Jackson, USA.
  • Velazquez AE; Radiation Oncology, University of Mississippi Medical Center, Jackson, USA.
  • Salvemini JD; Radiation Oncology, University of Mississippi Medical Center, Jackson, USA.
  • Vance GR; Radiation Oncology, University of Mississippi Medical Center, Jackson, USA.
  • Grady CC; Radiation Oncology, University of Mississippi Medical Center, Jackson, USA.
  • Hathaway B; Radiation Oncology, University of Mississippi Medical Center, Jackson, USA.
  • Roux JA; Radiation Oncology, University of Mississippi Medical Center, Jackson, USA.
  • Vijayakumar S; Radiation Oncology, University of Mississippi Medical Center, Jackson, USA.
Cureus ; 16(2): e53733, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38455773
ABSTRACT
With the success of the Human Genome Project, the era of genomic medicine (GM) was born. Later on, as GM made progress, there was a feeling of exhilaration that GM could help resolve many disease processes. It also led to the conviction that personalized medicine was possible, and a relatively synonymous word, precision medicine (PM), was coined. However, the influence of environmental factors and social determinants of diseases was only partially given their due importance in the definition of PM, although more recently, this has been recognized. With the rapid advances in GM, big data, data mining, wearable devices for health monitoring, telemedicine, etc., PM can be more easily extended to population-level health care in disease management, prevention, early screening, and so on.and the term precision population medicine (PPM) more aptly describes it. PPM's potential in cancer care was posited earlier,and the current authors planned a series of cancer disease-specific follow-up articles. These papers are mainly aimed at helping emerging students in health sciences (medicine, pharmacy, nursing, dentistry, public health, population health), healthcare management (health-focused business administration, nonprofit administration, public institutional administration, etc.), and policy-making (e.g., political science), although not exclusively. This first disease-specific report focuses on the cancer of the uterine cervix (CC). It describes how recent breakthroughs can be leveraged as force multipliers to improve outcomes in CC - by improving early detection, better screening for CC, potential GM-based interventions during the stage of persistent Human papillomavirus (HPV) infection and treatment interventions - especially among the disadvantaged and resource-scarce populations. This work is a tiny step in our attempts to improve outcomes in CC and ultimately eradicate CC from the face of the earth.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos